Key features include intuitive usability, highlighted by an integrated display that enhances patient understanding of scan results and supports informed treatment decisions.
Dentsply Sirona announced that Primescan 2 Cart has been honored with the 2026 Red Dot Award: Product Design , one of the world’s most respected design competitions. The award recognizes the company’s commitment to developing innovative technologies that combine outstanding functionality, intuitive usability, and exceptional design.
Primescan 2 Cart supports efficient workflows and greater flexibility for dental practices. Its compact footprint, ergonomic design, and mobility allow clinicians to seamlessly integrate digital scanning into everyday practice while enhancing patient communication.
Designed with both clinicians and patients in mind, Primescan 2 Cart features optimized dimensions to improve access during scanning procedures, a streamlined surface that supports efficient disinfection, and an integrated display that enhances patient understanding and engagement.
“At Dentsply Sirona, we are committed to creating solutions that make digital dentistry more efficient, intuitive, and accessible,” said Johannes Krug, vice president of Connected Technology Solutions at Dentsply Sirona. “This Red Dot Award reflects our dedication to combining technology with thoughtful design to help dental professionals deliver exceptional patient care.”
The Red Dot Design Award is one of the world’s leading design competitions, recognizing excellence in Product Design, Brands & Communication Design, and Design Concept. Judged by independent international experts, the award celebrates innovative solutions that combine outstanding design, functionality, and business value.
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with more than a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive portfolio of solutions, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands.
Dentsply Sirona’s innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The company’s shares are listed in the United States on Nasdaq under the symbol XRAY.
Source: https://www.dentsplysirona.com/
Products 17 November 2026
Dentsply Sirona Manufactures 100,000th Heliodent Plus X-Ray Unit
The 100,000-unit milestone reflects decades of clinician trust and the growing importance of connected imaging workflows in modern dentistry.
News 30 October 2026
News 23 October 2026
Dentsply Sirona, Midwest Dental Expand Technology Relationship
Beginning November 1, Dentsply Sirona will expand its long-standing relationship with Midwest Dental Equipment & Supply beyond consumables to include its complete technology portfo
News 30 September 2026
Dentsply Sirona Completes 2026 Ultrasonic Scaling Teaching Institute
Dentsply Sirona welcomed key dental hygiene and periodontal faculty from across the US and Canada to DS Academy in Charlotte, North Carolina, for hands-on training, curriculum deve
News 14 September 2026
Dentsply Sirona Completes 2026 Ultrasonic Scaling Teaching Institute
Dentsply Sirona welcomed key dental hygiene and periodontal faculty from across the US and Canada to DS Academy in Charlotte, North Carolina, for hands-on training, curriculum deve
News 20 November 2026
New Service Combines In-Office Photography, Custom Creative Content, and a Yearlong Posting Plan to Help Patients Get to Know the People Behind Their Care
News 20 November 2026
Dr. Cesar Tapia Awarded American College of Dentists Fellowship
Cesar Tapia, founder of ConfiDENT in Alpharetta and Cumming, Georgia, was awarded Fellowship in the American College of Dentists on October 24, 2026, during the College’s Annual Me
Editorials 20 November 2026
When the Food and Drug Administration issued a safety warning in 2022 about severe tooth decay associated with a commonly prescribed orally dissolving opioid use disorder medicatio
Prosthodontics 20 November 2026
This peer-reviewed prosthodontics article summarizes clinical evidence from BMC oral health (2025). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
Products 19 November 2026
FDA Grants Breakthrough Designation to OraLiva Oral Cancer Test
Investigational cytology test is designed to help clinicians assess suspicious oral lesions with a quantitative index.